UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052989
Receipt number R000060452
Scientific Title Effect of research food consumption on Nasal Discomforts
Date of disclosure of the study information 2023/12/15
Last modified on 2023/12/04 14:33:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of research food consumption on Nasal Discomforts

Acronym

Effect of research food consumption on Nasal Discomforts

Scientific Title

Effect of research food consumption on Nasal Discomforts

Scientific Title:Acronym

Effect of research food consumption on Nasal Discomforts

Region

Japan


Condition

Condition

Healthy

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to effects of consuming the study foods on those with nasal discomfort by comparing them to the non-treatment group.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

nasal discomfort

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of test foods (research foods)

Interventions/Control_2

No treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Healthy Japanese over 12 years old
(2) If over 18 years of age and with sufficient capacity to make decisions, those who can obtain the individual's consent
(3) If under 18 years of age, those with parental consent
(4) Subjects who related to Shizuoka Prefecture sports club teams
(5) Subjects who have nasal discomfort during the period from February to April
(6) Subjects who able to maintain a consistent daily lifestyle during the study period.

Key exclusion criteria

(1) Subjects who are currently receiving medication for some disease.
(2) Subjects with serious diseases (diabetes, heart disease, cancer, etc.) or mental illness.
(3) Subjects with a history of serious diseases (diabetes, heart disease, liver disease, renal disease, cancer, etc.) in the past.
(4) Subjects receiving desensitization therapy
(5) Subjects with possible food or drug allergies to the test foods.
(6) Subjects who are otherwise ineligible for participation in this study by the investigater.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Ryosuke
Middle name
Last name Mastuoka

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

182-0002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Email

ryosuke_mastuoka@kewpie.co.jp


Public contact

Name of contact person

1st name Fumika
Middle name
Last name Kamijo

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

182-0002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Homepage URL


Email

fumika_kamijo@kewpie.co.jp


Sponsor or person

Institute

Kewpie Corporation

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

Tel

03-6240-1162

Email

info@ueno-asagao.clinic


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2023 Year 12 Month 15 Day

Last follow-up date

2024 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 12 Month 04 Day

Last modified on

2023 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060452


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name